Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.36 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.30 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13446458 | 0.97 | FFAR3 (0.38) | CYP2C19FFAR3AKR1C1ALDH1A1TSHR | |
| SCHEMBL1091337 | 0.92 | FFAR3 (0.38) | CYP2C19FFAR3ALDH1A1TSHR | |
| SCHEMBL1091552 | 0.87 | FFAR3 (0.41) | FFAR3ALDH1A1TSHR | |
| SCHEMBL11379072 | 0.83 | CYP2C19 (0.37) | CYP2C19FFAR3AKR1C1USP2ALDH1A1 | |
| SCHEMBL11373556 | 0.83 | CYP2C19 (0.37) | CYP2C19FFAR3AKR1C1USP2ALDH1A1 | |
| SCHEMBL28038472 | 0.82 | CYP2C19 (0.30) | CYP2C19 | |
| SCHEMBL14825438 | 0.80 | ALDH1A1 (0.31) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL1464652 | 0.80 | ALDH1A1 (0.35) | CYP2C19USP2ALDH1A1LMNACYP1A2 | |
| SCHEMBL2761157 | 0.79 | — | — | |
| SCHEMBL13446470 | 0.78 | FFAR3 (0.40) | FFAR3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 305 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3253561-B1 | PROCESS FOR PRODUCING MODIFIED OLEFIN POLYMER IN AN EXTRUDER | BOREALIS AG (AT) | 2019-05-08 | — | — | EP | claimed |
| US-10105908-B2 | Process for producing modified olefin polymer in an extruder | BOREALIS AG (AT) | 2018-10-23 | — | — | US | claimed |
| CN-108373623-A | A kind of water-repellent paint for bridge | 周晓雪 | 2018-08-07 | — | — | CN | claimed |
| US-20170361543-A1 | Process for Producing Modified Olefin Polymer in an Extruder | BOREALIS AG (AT) | 2017-12-21 | — | — | US | claimed |
| WO-2016124617-A1 | PROCESS FOR PRODUCING MODIFIED OLEFIN POLYMER IN AN EXTRUDER | BOREALIS AG (AT) | 2016-08-11 | — | — | WO | claimed |
| CN-105348879-A | Waterproof agent for bridge | CHUZHOU SIMAITE COMPOSITE MATERIAL CO LTD | 2016-02-24 | — | — | CN | claimed |
| EP-0222157-B1 | RESIN COMPOSITION | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1992-12-30 | — | — | EP | claimed |
| US-12605917-B2 | Multilayer sheet comprising a foamed layer suitable for food packaging | BOREALIS AG (AT) | 2026-04-21 | — | — | US | disclosed |
| EP-4630407-A1 | 2-METHYL-2-(1-METHYLCYCLOHEXYL)PROPANAMIDE DERIVATIVES AND 1-(TERT-BUTYL)-CYCLOHEXANE-1-CARBOXAMIDE DERIVATIVES FOR USE IN UMAMI FLAVOR COMPOSITIONS | International Flavors & Fragrances, Inc. (US) | 2025-10-15 | — | — | EP | disclosed |
| US-20240247140-A1 | FLAME RETARDANT COMPOSITION COMPRISING A HIGH MELT STRENGTH POLYPROPYLENE | BOREALIS AG (AT) | 2024-07-25 | — | — | US | disclosed |
| WO-2024141547-A1 | PROPYLENE COMPOSITION | BOREALIS AG (AT) | 2024-07-04 | — | — | WO | disclosed |
| EP-4393969-A1 | PROPYLENE COMPOSITION | Borealis AG (AT) | 2024-07-03 | — | — | EP | disclosed |
| EP-3487927-B1 | STIFF PROPYLENE COMPOSITION WITH GOOD DIMENSIONAL STABILITY AND EXCELLENT SURFACE APPEARANCE | BOREALIS AG (AT) | 2024-03-27 | — | — | EP | disclosed |
| US-6204348-B1 | REACTING A POLYPROPYLENE WITH ETHYLENICALLY UNSATURATED MONOMER | BOREALIS GMBH (AT) | 2001-03-20 | — | — | US | disclosed |
| US-6136926-A | CURING WITH ETHYLENICALLY UNSATURATED ORGANOSILANE COMPOUND; HEATING BELOW SOFTENING POINT | BOREALIS GMBH (AT) | 2000-10-24 | — | — | US | disclosed |
| US-5962594-A | Segmented polyolefins | BOREALIS AG (AT) | 1999-10-05 | — | — | US | disclosed |
| US-5929127-A | Fine-celled polyolefin foam materials | BOREALIS AG (AT) | 1999-07-27 | — | — | US | disclosed |
| EP-0792894-A2 | Continuous modification of polyolefins in solid phase | PCD-Polymere Gesellschaft m.b.H. (AT) | 1997-09-03 | — | — | EP | disclosed |
| US-4283420-A | ANTICONVULSANTS, ANTIANAPHYLACTIC AGENTS, ANTIPSYCHOTIC AGENTS | LABAZ (FR) | 1981-08-11 | — | — | US | disclosed |
| US-4064110-A | FROM 5-ALKOXYMETHYL-1,3,4-DIOXAZOL-2-ONES, ALKALI METAL CARBOXYLATE CATALYST | BAYER AKTIENGESELLSCHAFT (DT) | 1977-12-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12605917-B2 | Multilayer sheet comprising a foamed layer suitable for food packaging | PTGER3, MFAP1, TAS2R13 | CYP2C19 3037/4885FFAR3 175/4885AKR1C1 2218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.